Degenerative Disc Disease Treatment Market Size & Share 2023 to 2032
Market Size by Product Type (Drugs {Acetaminophen, NSAIDs, Muscle Relaxants, Steroids, Route of Administration [Oral, Injectable]} Devices {Cervical, Lumbar}).
Report ID: GMI5787
|
Published Date: May 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Degenerative Disc Disease Treatment Market Size
Degenerative Disc Disease Treatment Market size accounted for USD 24 billion in 2022 and is estimated to grow at 7.2% to reach USD 49.7 billion by 2032. Growing prevalence of degenerative bone diseases will positively influence the market growth.
Degenerative Disc Disease Treatment Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
For instance, in 2021, according to the Centers of Disease Control and Prevention (CDC), adults aged 65 years and above are more affected by degenerative bone disease. The CDC also estimated that nearly 78 million (26%) of U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. This indicates that there will huge number of patient pool suffering from degenerative bone disease. Such high prevalence of the disease will increase the product demand.
Degenerative disc disease (DDD) is a condition that affects the intervertebral discs in the spine, causing them to degenerate and lose their flexibility over time. Degenerative disc disease (DDD) treatment involves a stepwise approach to manage symptoms. Conservative measures like physical therapy, pain medications, and lifestyle modifications are commonly employed. In some cases, epidural steroid injections may be used to reduce inflammation. Also, surgical interventions like discectomy, spinal fusion, or artificial disc replacement may be considered for severe cases. The choice of treatment depends on symptom severity, disc degeneration, and individual health.
COVID-19 Impact
The COVID-19 pandemic has severely impacted the global economies with all the sectors witnessing a significant slump during 2020. The healthcare sector was one of the most severely impacted sectors during the pandemic owing to tremendous pressure on the healthcare systems to contain the spread of infection. Various non-essential surgical procedures were halted during the pandemic to control the spread of infection. As the degenerative disc disease procedures are noted to be non-emergency, these surgical procedures were suspended and postponed indefinitely during pandemic. Thus, low demand was observed for degenerative disc disease amidst the pandemic.
Degenerative Disc Disease Treatment Market Trends
Increasing rate of geriatric population is one of the major factors propelling the market demand. Rising prevalence of bone degenerative disorders such as osteoporosis and rheumatoid arthritis in the geriatric population is expected to boost the demand of degenerative disc disease treatment. Furthermore, geriatric population is more susceptible to the bone degenerative diseases such as spinal stenosis, osteophyte formation, osteomyelitis, degenerative disc herniation among others owing to immunocompromised nature of aging and increasing number of chronic comorbidities.
Degenerative Disc Disease Treatment Market Analysis
The treatment of degenerative disc disease (DDD) involves surgical interventions that often come with a high cost. Procedures such as discectomy, spinal fusion, artificial disc replacement are expensive, impacting access for patients with limited financial resources and inadequate insurance coverage. Thus, high cost of surgical interventions may act as a barrier, hindering patients from pursuing these treatment options and potentially limiting the growth of the DDD treatment industry. Also, post-surgical complications such as bleeding, nerve damage and inflammation may possibly impede the market share.
By product type, the degenerative disc disease treatment market is classified into drugs and devices. The devices segment accounted over 51% of the market share in 2022 and is projected to witness robust growth over the analysis timeframe. Degenerative disc disease (DDD) treatment involves the use of specialized devices in different areas of the spine that offers various benefits for managing DDD effectively. Cervical spine devices such as artificial discs provide stability, restore disc height and maintain proper alignment by reducing pain and improving functionality in the neck. Lumbar spine devices, such as interbody cages, pedicle screws address instability and nerve compression and offer support and restoring stability in the lower back.
Based on end-use, the degenerative disc disease treatment market is segmented into hospitals, clinics and others. The hospitals are expected to register USD 26.6 billion in 2032. Hospitals include specialized departments with skilled surgeons and advanced diagnostic technologies. Multidisciplinary care teams ensure personalized treatment plans and coordinated care for degenerative disc treatment that enables to attain improved patient outcomes. Furthermore, growing technological advancements in degenerative disc disease treatment and increase in hospital admissions for surgeries and treatments will further stimulate the market expansion.
North America degenerative disc disease treatment market accounted for over 57% business share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. Increasing prevalence of DDD, coupled with advancements in medical technology and growing geriatric population has significantly fueled the market size in the North America region. Furthermore, presence of key market players and favorable government regulation for novel drugs and devices development is expected to proliferate the regional market outlook.
Degenerative Disc Disease Treatment Market Share
Major market players operating in the degenerative disc disease treatment market include
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Some of the recent industry developments:
The degenerative disc disease treatment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Product Type
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →